HigA2 (Rv2021c) Is a Transcriptional Regulator with Multiple Regulatory Targets in

Overview

Journal Microorganisms

Specialty Microbiology

Date 2024 Jun 27

PMID 38930627

Authors

Mingyan Xu

Meikun Liu

Tong Liu

Xuemei Pan

Qi Ren

Tiesheng Han

Lixia Gou

Affiliations

Soon will be listed here.

Abstract

Toxin-antitoxin (TA) systems are the major mechanism for persister formation in (). Previous studies found that HigBA2 (Rv2022c-Rv2021c), a predicted type II TA system of , could be activated for transcription in response to multiple stresses such as anti-tuberculosis drugs, nutrient starvation, endure hypoxia, acidic pH, etc. In this study, we determined the binding site of HigA2 (Rv2021c), which is located in the coding region of the upstream gene (), and the conserved recognition motif of HigA2 was characterized via oligonucleotide mutation. Eight binding sites of HigA2 were further found in the genome according to the conserved motif. RT-PCR showed that HigA2 can regulate the transcription level of all eight of these genes and three adjacent downstream genes. DNA pull-down experiments showed that twelve functional regulators sense external regulatory signals and may regulate the transcription of the HigBA2 system. Of these, Rv0903c, Rv0744c, Rv0474, Rv3124, Rv2603c, and Rv3583c may be involved in the regulation of external stress signals. In general, we identified the downstream target genes and possible upstream regulatory genes of HigA2, which paved the way for the illustration of the persistence establishment mechanism in .

References

Hua C, Huang J, Wang T, Sun Y, Liu J, Huang L . Bacterial Transcription Factors Bind to Coding Regions and Regulate Internal Cryptic Promoters. mBio. 2022; 13(5):e0164322. PMC: 9600179. DOI: 10.1128/mbio.01643-22. View

Soo V, Wood T . Antitoxin MqsA represses curli formation through the master biofilm regulator CsgD. Sci Rep. 2013; 3:3186. PMC: 4894380. DOI: 10.1038/srep03186. View

Rustad T, Harrell M, Liao R, Sherman D . The enduring hypoxic response of Mycobacterium tuberculosis. PLoS One. 2008; 3(1):e1502. PMC: 2198943. DOI: 10.1371/journal.pone.0001502. View

Berney M, Cook G . Unique flexibility in energy metabolism allows mycobacteria to combat starvation and hypoxia. PLoS One. 2010; 5(1):e8614. PMC: 2799521. DOI: 10.1371/journal.pone.0008614. View

De Bruyn P, Girardin Y, Loris R . Prokaryote toxin-antitoxin modules: Complex regulation of an unclear function. Protein Sci. 2021; 30(6):1103-1113. PMC: 8138530. DOI: 10.1002/pro.4071. View

Kamruzzaman M, Wu A, Iredell J . Biological Functions of Type II Toxin-Antitoxin Systems in Bacteria. Microorganisms. 2021; 9(6). PMC: 8230891. DOI: 10.3390/microorganisms9061276. View

Boldrin F, Provvedi R, Mazzabo L, Segafreddo G, Manganelli R . Tolerance and Persistence to Drugs: A Main Challenge in the Fight Against . Front Microbiol. 2020; 11:1924. PMC: 7479264. DOI: 10.3389/fmicb.2020.01924. View

Gao C, Yang M, He Z . An ArsR-like transcriptional factor recognizes a conserved sequence motif and positively regulates the expression of phoP in mycobacteria. Biochem Biophys Res Commun. 2011; 411(4):726-31. DOI: 10.1016/j.bbrc.2011.07.014. View

Johnson R, McDonough K . Cyclic nucleotide signaling in Mycobacterium tuberculosis: an expanding repertoire. Pathog Dis. 2018; 76(5). PMC: 6693379. DOI: 10.1093/femspd/fty048. View

10.

Bu L, Brooks 3rd C . De novo prediction of the structures of M. tuberculosis membrane proteins. J Am Chem Soc. 2008; 130(16):5384-5. DOI: 10.1021/ja710213p. View

11.

Zhang Y . Persisters, persistent infections and the Yin-Yang model. Emerg Microbes Infect. 2015; 3(1):e3. PMC: 3913823. DOI: 10.1038/emi.2014.3. View

12.

Eweda G, Suzuki D, Nagata T, Tsujimura K, Koide Y . Identification of murine T-cell epitopes on low-molecular-mass secretory proteins (CFP11, CFP17, and TB18.5) of Mycobacterium tuberculosis. Vaccine. 2010; 28(29):4616-25. DOI: 10.1016/j.vaccine.2010.04.079. View

13.

Mahmood N, Bhatti S, Abbas S, Shahid S, Nasir S . The pncA gene mutations of Mycobacterium tuberculosis in multidrug-resistant tuberculosis. Biotechnol Appl Biochem. 2021; 69(5):2195-2204. DOI: 10.1002/bab.2278. View

14.

Chi X, Chang Y, Li M, Lin J, Liu Y, Li C . Biochemical characterization of mt-PemIK, a novel toxin-antitoxin system in Mycobacterium tuberculosis. FEBS Lett. 2018; 592(24):4039-4050. DOI: 10.1002/1873-3468.13280. View

15.

Hicks N, Giffen S, Culviner P, Chao M, Dulberger C, Liu Q . Mutations in dnaA and a cryptic interaction site increase drug resistance in Mycobacterium tuberculosis. PLoS Pathog. 2020; 16(11):e1009063. PMC: 7738170. DOI: 10.1371/journal.ppat.1009063. View

16.

Agarwal S, Tiwari P, Deep A, Kidwai S, Gupta S, Thakur K . System-Wide Analysis Unravels the Differential Regulation and In Vivo Essentiality of Virulence-Associated Proteins B and C Toxin-Antitoxin Systems of Mycobacterium tuberculosis. J Infect Dis. 2018; 217(11):1809-1820. DOI: 10.1093/infdis/jiy109. View

17.

Gautam U, Mehra S, Kaushal D . In-Vivo Gene Signatures of Mycobacterium tuberculosis in C3HeB/FeJ Mice. PLoS One. 2015; 10(8):e0135208. PMC: 4535907. DOI: 10.1371/journal.pone.0135208. View

18.

Betts J, Lukey P, Robb L, McAdam R, Duncan K . Evaluation of a nutrient starvation model of Mycobacterium tuberculosis persistence by gene and protein expression profiling. Mol Microbiol. 2002; 43(3):717-31. DOI: 10.1046/j.1365-2958.2002.02779.x. View

19.

Balaban N, Helaine S, Lewis K, Ackermann M, Aldridge B, Andersson D . Definitions and guidelines for research on antibiotic persistence. Nat Rev Microbiol. 2019; 17(7):441-448. PMC: 7136161. DOI: 10.1038/s41579-019-0196-3. View

20.

Fasani R, Savageau M . Molecular mechanisms of multiple toxin-antitoxin systems are coordinated to govern the persister phenotype. Proc Natl Acad Sci U S A. 2013; 110(27):E2528-37. PMC: 3703989. DOI: 10.1073/pnas.1301023110. View